Episode 1650 • • 39:22 - 46:40
1650: Algo Juice
French Company Alstiag Develops Bipolar Disorder Blood Test
French company Alstiag has launched a blood test that uses AI to differentiate between depression and bipolar disorder by analyzing RNA sequences. The test aims to reduce misdiagnosis rates, which currently take six to eight years on average in France. While the company claims an 80% accuracy rate, skeptics question the validity of using a month-long blood analysis to diagnose complex mental health conditions.